Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Equine IgG Monoclonal Antibody

Cat. No.VD11N429

Product TypeAnimal-targeted Antibodies

Size

Product Overview

BioVenic mouse monoclonal antibody is specific for equine IgG. It is affinity purified by protein A. It can be applied to WB, IHC and IF/ICC assays of equine IgG.

Specifications

Application WB; IHC; IF/ICC
Clonality Monoclonal
Classification Primary Antibody
Clone D27N14
Host Mouse
Target Species Equine
Species Reactivity Equine
Specificity Equine IgG
Isotype IgG1
Immunogen Native protein of IgG
Purification Protein A Purified
Purity > 95%
Conjugation Unconjugated
Preservative and Stabilizer 0.05% Proclin 300
Buffer 0.01M Phosphate Buffered Saline, pH 7.4, 50% Glycerol
Physical State Liquid

Target Information

Equine IgG is the principal immunoglobulin found in the plasma of horses, representing up to 80% of the total immunoglobulin concentration. It plays a critical role in the immune response, particularly in opsonization and neutralization reactions. There are several subclasses of IgG in horses, including IgGa, IgGb, IgGc, and IgG(T), each with distinct physicochemical properties and immune functions. IgG is essential for the health of foals, especially in the context of passive immunity transfer, where insufficient acquisition of maternal immunoglobulins can lead to severe health risks.

Target Equine IgG

Shipping and Storage

This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Lewis, Melanie J., et al. "The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies." Molecular immunology 45.3 (2008): 818-827.
Inquiry Basket